MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma

[1]  M. Galasso,et al.  MiR‐16‐1‐3p and miR‐16‐2‐3p possess strong tumor suppressive and antimetastatic properties in osteosarcoma , 2019, International journal of cancer.

[2]  R. Safaralizadeh,et al.  MicroRNA replacement therapy in cancer , 2019, Journal of cellular physiology.

[3]  Yang Yang,et al.  Trends in the development of miRNA bioinformatics tools , 2019, Briefings Bioinform..

[4]  Lei Ding,et al.  Identification of biomarkers associated with the recurrence of osteosarcoma using ceRNA regulatory network analysis , 2019, International journal of molecular medicine.

[5]  Raghunath Chatterjee,et al.  Liquid biopsy: miRNA as a potential biomarker in oral cancer. , 2019, Cancer epidemiology.

[6]  F. van Nieuwerburgh,et al.  The presence of extracellular microRNAs in the media of cultured Drosophila cells , 2018, Scientific Reports.

[7]  Nanwei Xu,et al.  MiR-199b-5p promotes malignant progression of osteosarcoma by regulating HER2. , 2018, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[8]  B. Gabrielli,et al.  Aurora kinases are a novel therapeutic target for HPV-positive head and neck cancers. , 2018, Oral oncology.

[9]  Hongwei Chen,et al.  MicroRNA-466 inhibits osteosarcoma cell proliferation and induces apoptosis by targeting CCND1 , 2018, Experimental and therapeutic medicine.

[10]  A. Patiño-García,et al.  Variants in the 14q32 miRNA cluster are associated with osteosarcoma risk in the Spanish population , 2018, Scientific Reports.

[11]  Babak Otoukesh,et al.  Novel molecular insights and new therapeutic strategies in osteosarcoma , 2018, Cancer Cell International.

[12]  Liang Chen,et al.  MicroRNA-524 promotes cell proliferation by down-regulating PTEN expression in osteosarcoma , 2018, Cancer Cell International.

[13]  C. Peng,et al.  Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation , 2018, Front. Endocrinol..

[14]  Behzad Baradaran,et al.  Treating cancer with microRNA replacement therapy: A literature review , 2018, Journal of cellular physiology.

[15]  Lihua Li,et al.  miRNA-21 inhibition inhibits osteosarcoma cell proliferation by targeting PTEN and regulating the TGF-β1 signaling pathway , 2018, Oncology letters.

[16]  Dongqi Li,et al.  Deep RNA sequencing reveals the dynamic regulation of miRNA, lncRNAs, and mRNAs in osteosarcoma tumorigenesis and pulmonary metastasis , 2018, Cell Death & Disease.

[17]  Baojin Wu,et al.  iTRAQ-Based Proteomic Analysis reveals possible target-related proteins and signal networks in human osteoblasts overexpressing FGFR2 , 2018, Proteome Science.

[18]  T. Tuschl,et al.  Human plasma and serum extracellular small RNA reference profiles and their clinical utility , 2018, Proceedings of the National Academy of Sciences.

[19]  Jin-Ho Yang,et al.  miR-202-5p inhibits the migration and invasion of osteosarcoma cells by targeting ROCK1 , 2018, Oncology letters.

[20]  Yvonne Tay,et al.  Noncoding RNA:RNA Regulatory Networks in Cancer , 2018, International journal of molecular sciences.

[21]  L. Xue,et al.  Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage , 2018, Clinical Epigenetics.

[22]  Zhi Lv,et al.  MicroRNA‐134 inhibits osteosarcoma angiogenesis and proliferation by targeting the VEGFA/VEGFR1 pathway , 2018, The FEBS journal.

[23]  Jiake Xu,et al.  Diagnostic and prognostic implications of serum miR-101 in osteosarcoma , 2018, Cancer biomarkers : section A of Disease markers.

[24]  R. Wolff,et al.  Dysregulated genes and miRNAs in the apoptosis pathway in colorectal cancer patients , 2018, Apoptosis.

[25]  Wenbo Wang,et al.  MicroRNA-129-5p suppresses cell proliferation, migration and invasion via targeting ROCK1 in osteosarcoma. , 2018, Molecular medicine reports.

[26]  Zhen Liu,et al.  Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/β-catenin signaling in non-small-cell lung cancer , 2018, Cell Death & Disease.

[27]  Yu-Ze Song,et al.  Circular RNA hsa_circ_0001564 regulates osteosarcoma proliferation and apoptosis by acting miRNA sponge. , 2018, Biochemical and biophysical research communications.

[28]  Publisher's Note , 2018, Anaesthesia.

[29]  Fei Wang,et al.  MicroRNA-300 Regulates the Ubiquitination of PTEN through the CRL4BDCAF13 E3 Ligase in Osteosarcoma Cells , 2017, Molecular therapy. Nucleic acids.

[30]  Chen Li,et al.  Inhibition of miRNA-21 attenuates the proliferation and metastasis of human osteosarcoma by upregulating PTEN. , 2017, Experimental and therapeutic medicine.

[31]  W. Liu,et al.  MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma , 2017, The Journal of international medical research.

[32]  Ankush Bansal,et al.  A novel miRNA analysis framework to analyze differential biological networks , 2017, Scientific Reports.

[33]  Xiaolu Sun,et al.  MiR-598: A tumor suppressor with biomarker significance in osteosarcoma. , 2017, Life sciences.

[34]  E. Lane,et al.  EGF hijacks miR-198/FSTL1 wound-healing switch and steers a two-pronged pathway toward metastasis , 2017, The Journal of experimental medicine.

[35]  Yang Xu,et al.  MicroRNA-125a Regulates Cell Proliferation Via Directly Targeting E2F2 in Osteosarcoma , 2017, Cellular Physiology and Biochemistry.

[36]  G. Yin,et al.  MiR-143 regulates the proliferation and migration of osteosarcoma cells through targeting MAPK7. , 2017, Archives of biochemistry and biophysics.

[37]  P. Tassone,et al.  Circulating biomarkers in osteosarcoma: new translational tools for diagnosis and treatment , 2017, Oncotarget.

[38]  Ashish Ranjan Sharma,et al.  Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine , 2017, Molecular therapy. Nucleic acids.

[39]  Huiyuan Zhai,et al.  Upregulation of miR-125b is associated with poor prognosis and trastuzumab resistance in HER2-positive gastric cancer , 2017, Experimental and therapeutic medicine.

[40]  J. Wen,et al.  MicroRNA-34a inhibits tumor invasion and metastasis in osteosarcoma partly by effecting C-IAP2 and Bcl-2 , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[41]  Yu Shyr,et al.  Identification of active miRNA promoters from nuclear run-on RNA sequencing , 2017, Nucleic acids research.

[42]  P. Szodoray,et al.  MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren's syndrome , 2017, PloS one.

[43]  T. Ochiya,et al.  Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma , 2017, Oncotarget.

[44]  Yu Yang,et al.  MicroRNA-100 suppresses human osteosarcoma cell proliferation and chemo-resistance via ZNRF2 , 2017, Oncotarget.

[45]  Chao Qi,et al.  miR-150 is downregulated in osteosarcoma and suppresses cell proliferation, migration and invasion by targeting ROCK1 , 2017, Oncology letters.

[46]  Weidan Ji,et al.  Targeting MicroRNAs in Cancer Gene Therapy , 2017, Genes.

[47]  Hongyan Zhang,et al.  Dysregulation of micro-143-3p and BALBP1 contributes to the pathogenesis of the development of ovarian carcinoma. , 2016, Oncology reports.

[48]  M. Sohel,et al.  Extracellular/Circulating MicroRNAs: Release Mechanisms, Functions and Challenges , 2016 .

[49]  L. Cao,et al.  MiR-326 is a diagnostic biomarker and regulates cell survival and apoptosis by targeting Bcl-2 in osteosarcoma. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[50]  Junjie Niu,et al.  Serum miR-95-3p is a diagnostic and prognostic marker for osteosarcoma , 2016, SpringerPlus.

[51]  Shuai Li,et al.  Serum microRNA-17 functions as a prognostic biomarker in osteosarcoma , 2016, Oncology letters.

[52]  J. Liu,et al.  Serum miR-300 as a diagnostic and prognostic biomarker in osteosarcoma , 2016, Oncology letters.

[53]  Yangbai Sun,et al.  MiR-24-BIM-Smac/DIABLO axis controls the sensitivity to doxorubicin treatment in osteosarcoma , 2016, Scientific Reports.

[54]  George A. Calin,et al.  microRNA Therapeutics in Cancer — An Emerging Concept , 2016, EBioMedicine.

[55]  Jianwei Ren,et al.  Targeting miR-29 induces apoptosis of osteosarcoma MG-63 cells via regulation of TGF-β1/PUMA signal. , 2016, European review for medical and pharmacological sciences.

[56]  K. Sun,et al.  miR-497 as a potential serum biomarker for the diagnosis and prognosis of osteosarcoma. , 2016, European review for medical and pharmacological sciences.

[57]  G. Stein,et al.  WWOX and p53 Dysregulation Synergize to Drive the Development of Osteosarcoma. , 2016, Cancer research.

[58]  Hedwig Sutterlüty-Fall,et al.  MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells , 2016, PloS one.

[59]  Min Zhang,et al.  18F-FDG PET/CT for Monitoring the Response of Breast Cancer to miR-143-Based Therapeutics by Targeting Tumor Glycolysis , 2016, Molecular therapy. Nucleic acids.

[60]  A. Avan,et al.  Locked nucleic acid anti-miR-21 inhibits cell growth and invasive behaviors of a colorectal adenocarcinoma cell line: LNA-anti-miR as a novel approach , 2016, Cancer Gene Therapy.

[61]  Ankush Bansal,et al.  APOEε2 is Associated with Milder Clinical and Pathological Alzheimer's Disease , 2016, Annals of Neurosciences.

[62]  Yayi Xia,et al.  Association of circulating miR-125b and survival in patients with osteosarcoma–A single center experience , 2016, Journal of bone oncology.

[63]  B. Fuchs,et al.  Involvement and Clinical Aspects of MicroRNA in Osteosarcoma , 2016, International journal of molecular sciences.

[64]  Fariza Tahi,et al.  miRNAFold: a web server for fast miRNA precursor prediction in genomes , 2016, Nucleic Acids Res..

[65]  P. Goudarzi,et al.  Down-regulation of microRNA-182 and microRNA-183 predicts progression of osteosarcoma , 2016, Archives of medical science : AMS.

[66]  N. Kushlinskii,et al.  Molecular mechanisms and microRNAs in osteosarcoma pathogenesis , 2016, Biochemistry (Moscow).

[67]  Junbo Dong,et al.  miRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma , 2016, Journal of bone oncology.

[68]  Huagang Pan,et al.  MicroRNA-143 promotes apoptosis of osteosarcoma cells by caspase-3 activation via targeting Bcl-2. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[69]  Ning Li,et al.  MicroRNA-20b Downregulates HIF-1α and Inhibits the Proliferation and Invasion of Osteosarcoma Cells , 2016, Oncology research.

[70]  Lijie Wang,et al.  MicroRNA-198 inhibited tumorous behaviors of human osteosarcoma through directly targeting ROCK1. , 2016, Biochemical and biophysical research communications.

[71]  Xiaoming Dai,et al.  Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma , 2016, Pathology & Oncology Research.

[72]  Huilin Yang,et al.  Aberrant expression of microRNA-99a and its target gene mTOR associated with malignant progression and poor prognosis in patients with osteosarcoma , 2016, OncoTargets and therapy.

[73]  Ming-Ling Kuo,et al.  miR-23∼27∼24 clusters control effector T cell differentiation and function , 2016, The Journal of experimental medicine.

[74]  Y. Qi,et al.  MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion via Targeting IGF-1R , 2016, Cellular Physiology and Biochemistry.

[75]  J. Yakisich,et al.  Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death , 2016, Cell Death & Disease.

[76]  A. Giordano,et al.  Let‐7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma‐Derived 3AB‐OS Cancer Stem Cells , 2016, Journal of cellular physiology.

[77]  G. Tu,et al.  MicroRNA-21 promotes proliferation, invasion and suppresses apoptosis in human osteosarcoma line MG63 through PTEN/Akt pathway , 2016, Tumor Biology.

[78]  Zhen Liu,et al.  MiR-125b Functions as a Tumor Suppressor and Enhances Chemosensitivity to Cisplatin in Osteosarcoma , 2016, Technology in cancer research & treatment.

[79]  Most Mauluda Akhtar,et al.  Bioinformatic tools for microRNA dissection , 2015, Nucleic acids research.

[80]  Xiancheng Liu,et al.  MiR-221 increases osteosarcoma cell proliferation, invasion and migration partly through the downregulation of PTEN. , 2015, International journal of molecular medicine.

[81]  Hongliang Liu,et al.  Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[82]  Javier Ardila-Molano,et al.  Circulating microRNAs as potential cancer biomarkers , 2015 .

[83]  J. Bu,et al.  MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma. , 2015, Oncology letters.

[84]  Yongming Xi,et al.  Oncogenic and Therapeutic Targeting of PTEN Loss in Bone Malignancies , 2015, Journal of cellular biochemistry.

[85]  Jie Chen,et al.  Role of MAPK7 in cell proliferation and metastasis in ovarian cancer. , 2015, International journal of clinical and experimental pathology.

[86]  Carlo M. Croce,et al.  miR-15b/16-2 deletion promotes B-cell malignancies , 2015, Proceedings of the National Academy of Sciences.

[87]  E. Anders Kolb,et al.  MicroRNAs and Potential Targets in Osteosarcoma: Review , 2015, Front. Pediatr..

[88]  R. Aqeilan,et al.  Tumor Suppressor WWOX inhibits osteosarcoma metastasis by modulating RUNX2 function , 2015, Scientific Reports.

[89]  Zenong Yuan,et al.  Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma. , 2015, International journal of clinical and experimental pathology.

[90]  Jayashree Ramana,et al.  TCGDB: A Compendium of Molecular Signatures of Thyroid Cancer and Disorders , 2015 .

[91]  Hong Zhu,et al.  The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma , 2015, Cellular Physiology and Biochemistry.

[92]  Junfeng Zhang,et al.  Identification of miR-199a-5p in serum as noninvasive biomarkers for detecting and monitoring osteosarcoma , 2015, Tumor Biology.

[93]  Jian Zhang,et al.  MiRNA-15a inhibits proliferation, migration and invasion by targeting TNFAIP1 in human osteosarcoma cells. , 2015, International journal of clinical and experimental pathology.

[94]  Haopeng Li,et al.  miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2 , 2015, Tumor Biology.

[95]  Shu-Jun Zhang,et al.  MicroRNAs in osteosarcoma. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[96]  Min Wei,et al.  MicroRNA-144 suppresses osteosarcoma growth and metastasis by targeting ROCK1 and ROCK2 , 2015, Oncotarget.

[97]  Jie Tang,et al.  Diagnostic and prognostic potentials of microRNA-27a in osteosarcoma. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[98]  M. Guo,et al.  miR-25 promotes glioma cell proliferation by targeting CDKN1C. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[99]  Liwen Wu,et al.  Identification of a Plasma Four-microRNA Panel as Potential Noninvasive Biomarker for Osteosarcoma , 2015, PloS one.

[100]  Baoan Ma,et al.  MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1 , 2015, Oncotarget.

[101]  Y. Wang,et al.  Low miR-34a and miR-192 are associated with unfavorable prognosis in patients suffering from osteosarcoma. , 2015, American journal of translational research.

[102]  L. Fan,et al.  Effect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR , 2014, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[103]  Yong Han,et al.  miR‐99a directly targets the mTOR signalling pathway in breast cancer side population cells , 2014, Cell proliferation.

[104]  Robert D. Finn,et al.  Rfam 12.0: updates to the RNA families database , 2014, Nucleic Acids Res..

[105]  Lucila Ohno-Machado,et al.  miRIAD—integrating microRNA inter- and intragenic data , 2014, Database J. Biol. Databases Curation.

[106]  Jianning Zhao,et al.  MiR-143 inhibits EGFR-signaling-dependent osteosarcoma invasion , 2014, Tumor Biology.

[107]  M. Gong,et al.  Circulating miR-148a is a significant diagnostic and prognostic biomarker for patients with osteosarcoma , 2014, Tumor Biology.

[108]  C. Della Rocca,et al.  Ezrin silencing remodulates the expression of Phosphoinositide-specific Phospholipase C enzymes in human osteosarcoma cell lines , 2014, Journal of Cell Communication and Signaling.

[109]  Jun Fang,et al.  Prognostic value of the microRNA-29 family in patients with primary osteosarcomas , 2014, Medical Oncology.

[110]  Yihe Hu,et al.  microRNA-145 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1. , 2014, Molecular medicine reports.

[111]  Baoxin Li,et al.  The Tumor Suppressor Role of miR-124 in Osteosarcoma , 2014, PloS one.

[112]  L. Dai,et al.  Serum miR-9 as a prognostic biomarker in patients with osteosarcoma , 2014, The Journal of international medical research.

[113]  Wei Chen,et al.  MicroRNA-199a-3p and microRNA-34a regulate apoptosis in human osteosarcoma cells , 2014, Bioscience reports.

[114]  S. Kauppinen,et al.  Development of microRNA therapeutics is coming of age , 2014, EMBO molecular medicine.

[115]  Haopeng Li,et al.  Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma. , 2014, International journal of clinical and experimental pathology.

[116]  Y. Kitagishi,et al.  The tumor suppressor PTEN interacts with p53 in hereditary cancer (Review). , 2014, International journal of oncology.

[117]  J. Squire,et al.  Digital Expression Profiling Identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as Potential Predictive Biomarkers for Neo-Adjuvant Chemotherapy Response in Paediatric Osteosarcoma , 2014, PloS one.

[118]  R. Bak,et al.  miRNA sponges: soaking up miRNAs for regulation of gene expression , 2014, Wiley interdisciplinary reviews. RNA.

[119]  Tetsuro Ohba,et al.  Autocrine VEGF/VEGFR1 Signaling in a Subpopulation of Cells Associates with Aggressive Osteosarcoma , 2014, Molecular Cancer Research.

[120]  P. Canoll,et al.  PI3K and Bcl-2 Inhibition Primes Glioblastoma Cells to Apoptosis through Downregulation of Mcl-1 and Phospho-BAD , 2014, Molecular Cancer Research.

[121]  Haopeng Li,et al.  Combined Elevation of microRNA-196a and microRNA-196b in Sera Predicts Unfavorable Prognosis in Patients with Osteosarcomas , 2014, International journal of molecular sciences.

[122]  L. Tang,et al.  MiR-99a Antitumor Activity in Human Breast Cancer Cells through Targeting of mTOR Expression , 2014, PloS one.

[123]  Haidong Xu,et al.  Tumor-Suppressing Effects of miR-429 on Human Osteosarcoma , 2014, Cell Biochemistry and Biophysics.

[124]  Cao Yang,et al.  miR-17 inhibitor suppressed osteosarcoma tumor growth and metastasis via increasing PTEN expression. , 2014, Biochemical and biophysical research communications.

[125]  Kun Li,et al.  Clinical significance of microRNA-183/Ezrin axis in judging the prognosis of patients with osteosarcoma , 2014, Medical Oncology.

[126]  C. Xiao,et al.  microRNA-17~92 is a powerful cancer driver and a therapeutic target , 2014, Cell cycle.

[127]  C. Ruiz,et al.  Upregulation of the miR-17-92 cluster and its two paraloga in osteosarcoma – reasons and consequences , 2014, Genes & cancer.

[128]  Lihua Li,et al.  MiR-133b Is Down-Regulated in Human Osteosarcoma and Inhibits Osteosarcoma Cells Proliferation, Migration and Invasion, and Promotes Apoptosis , 2013, PloS one.

[129]  Ana Kozomara,et al.  miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..

[130]  X. Chen,et al.  Wilms’ tumour suppressor gene 1 (WT1) is involved in the carcinogenesis of Lung cancer through interaction with PI3K/Akt pathway , 2013, Cancer Cell International.

[131]  I. Rigoutsos,et al.  The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease , 2013, Cell Death and Differentiation.

[132]  H. Zhang,et al.  MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1. , 2013, Bone.

[133]  Wei Zhao,et al.  miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells , 2013, Molecular and Cellular Biochemistry.

[134]  Wei Wang,et al.  MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1. , 2013, Biochemical and biophysical research communications.

[135]  Hyun-Sook Kim,et al.  MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma. , 2013, Human pathology.

[136]  Lei Song,et al.  MicroRNA-24 inhibits osteosarcoma cell proliferation both in vitro and in vivo by targeting LPAATβ. , 2013, Archives of biochemistry and biophysics.

[137]  Jingru Zhang,et al.  Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling. , 2013, Carcinogenesis.

[138]  M. Tania,et al.  MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects , 2013, Tumor Biology.

[139]  Yong Huang,et al.  miR‐16 inhibits cell proliferation by targeting IGF1R and the Raf1–MEK1/2–ERK1/2 pathway in osteosarcoma , 2013, FEBS letters.

[140]  David H. Mathews,et al.  RNAstructure: web servers for RNA secondary structure prediction and analysis , 2013, Nucleic Acids Res..

[141]  Quan Gao,et al.  MicroRNA-34a Inhibits Human Osteosarcoma Proliferation by Downregulating Ether à go-go 1 Expression , 2013, International journal of medical sciences.

[142]  L. Ouyang,et al.  A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma , 2013, Medical Oncology.

[143]  L. Deng,et al.  MicroRNA-17-92a upregulation by estrogen leads to Bim targeting and inhibition of osteoblast apoptosis , 2013, Journal of Cell Science.

[144]  P. Picci,et al.  miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control. , 2013, International Journal of Oncology.

[145]  Laszlo Nagy,et al.  A Versatile Method to Design Stem-Loop Primer-Based Quantitative PCR Assays for Detecting Small Regulatory RNA Molecules , 2013, PloS one.

[146]  Sujia Wu,et al.  MicroRNAs in osteosarcoma: From biological players to clinical contributors, a review , 2013, The Journal of international medical research.

[147]  C. Xiao,et al.  MicroRNA-221 Induces Cell Survival and Cisplatin Resistance through PI3K/Akt Pathway in Human Osteosarcoma , 2013, PloS one.

[148]  A. Cleton-Jansen,et al.  MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma , 2013, Orphanet Journal of Rare Diseases.

[149]  Xiaoping Zhou,et al.  Identification of Serum MicroRNA-21 as a Biomarker for Chemosensitivity and Prognosis in Human Osteosarcoma , 2012, The Journal of international medical research.

[150]  E. Kleinerman,et al.  Multiple receptor tyrosine kinases promote the in vitro phenotype of metastatic human osteosarcoma cell lines , 2012, Oncogenesis.

[151]  Anne-Marie Cleton-Jansen,et al.  Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs , 2012, PloS one.

[152]  H. H. Andersen,et al.  A Systematic Review of MicroRNA in Glioblastoma Multiforme: Micro-modulators in the Mesenchymal Mode of Migration and Invasion , 2012, Molecular Neurobiology.

[153]  J. Prehn,et al.  Targeting the anti-apoptotic Bcl-2 family members for the treatment of cancer. , 2012, Experimental oncology.

[154]  Haien Zhao,et al.  miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells , 2012, International journal of molecular medicine.

[155]  W. Zhang,et al.  The microRNA-29 plays a central role in osteosarcoma pathogenesis and progression , 2012, Molecular Biology.

[156]  Y. Juliano,et al.  MAPK7 and MAP2K4 as prognostic markers in osteosarcoma. , 2012, Human pathology.

[157]  Frederick Luk,et al.  Microparticle conferred microRNA profiles - implications in the transfer and dominance of cancer traits , 2012, Molecular Cancer.

[158]  D. Gupta,et al.  Identification of mirtrons in rice using MirtronPred: a tool for predicting plant mirtrons. , 2012, Genomics.

[159]  M. Bushell,et al.  microRNAs in cancer management. , 2012, The Lancet. Oncology.

[160]  Junfeng Zhu,et al.  Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin. , 2012, The American journal of pathology.

[161]  M. Rosemann,et al.  MicroRNA profiling with correlation to gene expression revealed the oncogenic miR-17-92 cluster to be up-regulated in osteosarcoma. , 2012, Cancer genetics.

[162]  B. Dawson,et al.  miRNA-34c regulates Notch signaling during bone development. , 2012, Human molecular genetics.

[163]  Z. Duan,et al.  MicroRNA Involvement in Osteosarcoma , 2012, Sarcoma.

[164]  Kevin B. Jones,et al.  miRNA signatures associate with pathogenesis and progression of osteosarcoma. , 2012, Cancer research.

[165]  S. Batra,et al.  Allelic Loss of 10q23.3, the PTEN Gene Locus in Cervical Carcinoma from Northern Indian Population , 2012, Pathology & Oncology Research.

[166]  Baoan Ma,et al.  MicroRNA-34a Inhibits the Proliferation and Metastasis of Osteosarcoma Cells Both In Vitro and In Vivo , 2012, PloS one.

[167]  E. Kleinerman,et al.  miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. , 2012, Cancer research.

[168]  J. Kjems,et al.  MicroRNA cloning and sequencing in osteosarcoma cell lines: differential role of miR-93 , 2012, Cellular Oncology.

[169]  A. Üren,et al.  Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells , 2012, Oncogene.

[170]  Jia Chen,et al.  miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3. , 2011, Biochemical and biophysical research communications.

[171]  P. Stadler,et al.  ViennaRNA Package 2.0 , 2011, Algorithms for Molecular Biology : AMB.

[172]  Wei Zhang,et al.  Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma , 2011, Cancer.

[173]  Ajit S. Narang,et al.  Subcellular Fate and Off-Target Effects of siRNA, shRNA, and miRNA , 2011, Pharmaceutical Research.

[174]  Giuseppe Basso,et al.  MiR-34a Targeting of Notch Ligand Delta-Like 1 Impairs CD15+/CD133+ Tumor-Propagating Cells and Supports Neural Differentiation in Medulloblastoma , 2011, PloS one.

[175]  Sebastian D. Mackowiak,et al.  miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades , 2011, Nucleic acids research.

[176]  Thomas D. Schmittgen,et al.  microRNA Replacement Therapy for Cancer , 2011, Pharmaceutical Research.

[177]  Zhenfeng Duan,et al.  MicroRNA-199a-3p Is Downregulated in Human Osteosarcoma and Regulates Cell Proliferation and Migration , 2011, Molecular Cancer Therapeutics.

[178]  Li Guo,et al.  Next-Generation Sequencing of MicroRNAs for Breast Cancer Detection , 2011, Journal of biomedicine & biotechnology.

[179]  Ana M. Aransay,et al.  miRanalyzer: an update on the detection and analysis of microRNAs in high-throughput sequencing experiments , 2011, Nucleic Acids Res..

[180]  K. Kelnar,et al.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. , 2011, Nature medicine.

[181]  Osamu Nakamura,et al.  The role of MAPK pathway in bone and soft tissue tumors. , 2011, Anticancer research.

[182]  Yong Zhu,et al.  mTOR/p70S6K Signal transduction pathway contributes to osteosarcoma progression and patients’ prognosis , 2010, Medical oncology.

[183]  Dieter Jocham,et al.  A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. , 2010, Urologic oncology.

[184]  Margaret S. Ebert,et al.  Pretty Boots Ankle Ugg Chestnut Short Classic Boots Womens 7qY1r7 , 2010 .

[185]  Andre J. van Wijnen,et al.  A network connecting Runx2, SATB2, and the miR-23a∼27a∼24-2 cluster regulates the osteoblast differentiation program , 2010, Proceedings of the National Academy of Sciences.

[186]  Kevin B. Jones,et al.  Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression. , 2010, Cancer research.

[187]  C. Croce,et al.  MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. , 2010, Cancer research.

[188]  Christine Feig,et al.  CD95/Fas promotes tumour growth , 2010, Nature.

[189]  C. Sander,et al.  Target mRNA abundance dilutes microRNA and siRNA activity , 2010, Molecular systems biology.

[190]  M. Loda,et al.  Identification of the miR-106b~25 MicroRNA Cluster as a Proto-Oncogenic PTEN-Targeting Intron That Cooperates with Its Host Gene MCM7 in Transformation , 2010, Science Signaling.

[191]  Jianning Tao,et al.  Alteration of Notch signaling in skeletal development and disease , 2010, Annals of the New York Academy of Sciences.

[192]  N. Kosaka,et al.  microRNA as a new immune-regulatory agent in breast milk , 2010, Silence.

[193]  C. Croce,et al.  miR-15a and miR-16-1 in cancer: discovery, function and future perspectives , 2010, Cell Death and Differentiation.

[194]  Li Li,et al.  Computational approaches for microRNA studies: a review , 2010, Mammalian Genome.

[195]  Andrea Califano,et al.  The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. , 2010, Cancer cell.

[196]  S. Lowe,et al.  miR-19 is a key oncogenic component of mir-17-92. , 2009, Genes & development.

[197]  D. Hughes.  How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize. , 2009, Cancer treatment and research.

[198]  L. Shan,et al.  [ShRNA of Cyclin D1 decreased the proliferation of human osteosarcoma cell line SOSP-9607.]. , 2009, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.

[199]  Lijun Liu,et al.  Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples. , 2009, Biochemical and biophysical research communications.

[200]  Yunqing Li,et al.  MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. , 2009, Cancer research.

[201]  Reuven Agami,et al.  The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. , 2009, Genes & development.

[202]  A. T. Freitas,et al.  Current tools for the identification of miRNA genes and their targets , 2009, Nucleic acids research.

[203]  Danish Sayed,et al.  MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. , 2008, Molecular biology of the cell.

[204]  A. Shet.  Characterizing blood microparticles: Technical aspects and challenges , 2008, Vascular health and risk management.

[205]  A. Harris,et al.  Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma , 2008, British journal of haematology.

[206]  Yi Tie,et al.  Downregulation of CCND1 and CDK6 by miR‐34a induces cell cycle arrest , 2008, FEBS letters.

[207]  J. Mendell.  miRiad Roles for the miR-17-92 Cluster in Development and Disease , 2008, Cell.

[208]  D. Iliopoulos,et al.  E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. , 2008, Cancer cell.

[209]  A. Ganser,et al.  Lentivirus-mediated antagomir expression for specific inhibition of miRNA function , 2007, Nucleic acids research.

[210]  Naoto Tsuchiya,et al.  Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells , 2007, Proceedings of the National Academy of Sciences.

[211]  W. Cho.  OncomiRs: the discovery and progress of microRNAs in cancers , 2007, Molecular Cancer.

[212]  Ying Feng,et al.  Supplemental Data P53-mediated Activation of Mirna34 Candidate Tumor-suppressor Genes , 2022 .

[213]  L. Lim,et al.  A microRNA component of the p53 tumour suppressor network , 2007, Nature.

[214]  Michael A. Beer,et al.  Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. , 2007, Molecular cell.

[215]  M. Peter,et al.  The CD95 Receptor: Apoptosis Revisited , 2007, Cell.

[216]  C. Croce,et al.  MicroRNA-133 controls cardiac hypertrophy , 2007, Nature Medicine.

[217]  R. Gorlick,et al.  Chemotherapy resistance in osteosarcoma: current challenges and future directions , 2006, Expert review of anticancer therapy.

[218]  R. Grimer,et al.  Vascular Endothelial Growth Factor Expression in Osteosarcoma , 2006, Clinical orthopaedics and related research.

[219]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[220]  R. Plasterk,et al.  RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain. , 2005, RNA.

[221]  W. Huttner,et al.  Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells , 2005, Journal of Cell Science.

[222]  David M. Thomas,et al.  Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma , 2004, The Journal of cell biology.

[223]  J. Wengel,et al.  LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA. , 2004, Biochemistry.

[224]  C. Croce,et al.  An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[225]  E. Canalis,et al.  Notch 1 impairs osteoblastic cell differentiation. , 2003, Endocrinology.

[226]  S. Hayashi,et al.  Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells. , 2003, Blood.

[227]  S. Knuutila,et al.  Amplification of 17p11.2∼p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma , 2002 .

[228]  David M. Livingston,et al.  A Complex with Chromatin Modifiers That Occupies E2F- and Myc-Responsive Genes in G0 Cells , 2002, Science.

[229]  Amy A. Caudy,et al.  Post-transcriptional gene silencing by double-stranded RNA , 2001, Nature Reviews Genetics.

[230]  J. Toppari,et al.  Bcl-w forms complexes with Bax and Bak, and elevated ratios of Bax/Bcl-w and Bak/Bcl-w correspond to spermatogonial and spermatocyte apoptosis in the testis. , 2000, Molecular endocrinology.

[231]  S. Artavanis-Tsakonas,et al.  Notch Signaling : Cell Fate Control and Signal Integration in Development , 1999 .

[232]  L. Cantley,et al.  New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[233]  P. Picci,et al.  C-myc and c-fos in Human Osteosarcoma: Prognostic Value of mRNA and Protein Expression , 1998, Oncology.

[234]  Y. Iwamoto,et al.  Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[235]  E. Wagner,et al.  c-fos-induced osteosarcoma formation in transgenic mice: cooperativity with c-jun and the role of endogenous c-fos. , 1995, Cancer research.

[236]  P. Lollini,et al.  The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. , 1995, Oncogene.

[237]  A. Ferber,et al.  Mitogenicity and transforming activity of the insulin-like growth factor-I receptor with mutations in the tyrosine kinase domain. , 1994, The Journal of biological chemistry.

[238]  Ye Liu,et al.  Low-expression of miR-7 promotes cell proliferation and exhibits prognostic value in osteosarcoma patients. , 2017, International journal of clinical and experimental pathology.

[239]  Wen-chang Lin,et al.  MetaMirClust: Discovery and Exploration of Evolutionarily Conserved miRNA Clusters. , 2016, Methods in molecular biology.

[240]  Hui Ling,et al.  Non-coding RNAs: Therapeutic Strategies and Delivery Systems. , 2016, Advances in experimental medicine and biology.

[241]  G. Cheng,et al.  Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy. , 2015, Advanced drug delivery reviews.

[242]  Q. Tian,et al.  A causal role for circulating miR-34b in osteosarcoma. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[243]  Haidong Xu,et al.  Tumor-Suppressing Effects of miR451 in Human Osteosarcoma , 2013, Cell Biochemistry and Biophysics.

[244]  X. Yu,et al.  Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis , 2013, Tumor Biology.

[245]  V. Thayanithy,et al.  Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma. , 2012, Bone.

[246]  Zhiguo Wang.  The guideline of the design and validation of MiRNA mimics. , 2011, Methods in molecular biology.

[247]  R. Nolo,et al.  Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness. , 2010, Oncogene.

[248]  Luigi Naldini,et al.  Stable knockdown of microRNA in vivo by lentiviral vectors , 2009, Nature Methods.

[249]  J. Freyssinet,et al.  Pathophysiologic significance of procoagulant microvesicles in cancer disease and progression , 2009, Hämostaseologie.

[250]  M. Peck-Radosavljevic,et al.  Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy. , 2006, Journal of hepatology.

[251]  A. Chott,et al.  Book Review , 2003, Modern Pathology.

[252]  S. Knuutila,et al.  Amplification of 17p11.2 approximately p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma. , 2002, Cancer genetics and cytogenetics.

[253]  P. Privalov,et al.  Calorimetric investigations on heat denaturation of cyanmetmyoglobin. , 1972, Molecular biology.